Investigation of the NMDA Antagonist Ketamine as a Treatment for Tinnitus
Clinical trial NCT03336398 · COMPLETED
Trial details
- NCT number
- NCT03336398
- Sponsor
- New York State Psychiatric Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2023-06-17
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.